Advertisement

Biological Trace Element Research

, Volume 142, Issue 3, pp 638–650 | Cite as

The Antioxidant and Antigenotoxic Effects of Pycnogenol® on Rats Treated With Cisplatin

  • Birsen AydinEmail author
  • Meftun Unsal
  • Zulal A. Sekeroglu
  • Yavuz Gülbahar
Article

Abstract

Oxidative stress and inflammation are implicated in the pathogenesis of cisplatin-induced toxicity. Pycnogenol® is known for its strong antioxidant and anti-inflammatory effects. In this study, the possible protective effects of pycnogenol on kidney, bone marrow, and red blood cells in rats treated with cisplatin were investigated. The rats were divided into four groups. Group 1 was the control and groups 2, 3, and 4 were orally treated with pycnogenol (200 mg/kg bw, o.p) for 5 days, treated with cisplatin (7 mg/kg bw, i.p.) on the fifth day and treated with cisplatin plus pycnogenol, respectively. Antioxidative parameters in kidney and red blood cells were measured. Chromosome anomalies in bone marrow and renal histopathology were also investigated. Activities of pro-oxidant enzymes (myeloperoxidase and xanthine oxidase), malondialdehyde, and nitric oxide levels significantly increased but antioxidant enzymes activities decreased in the kidneys and red blood cells after cisplatin treatment. Pycnogenol treatment prior to the administration of cisplatin significantly decreased cisplatin-induced injury, as evidenced by its normalizing these parameters. Chromosomal aberrations decreased and mitotic index frequencies increased in bone marrow treated with cisplatin plus pycnogenol. These findings suggest that pycnogenol may be a useful protective agent against the toxicity associated with cisplatin therapy.

Keywords

Cisplatin Pycnogenol® Oxidative stress Antioxidant enzymes Chromosomal aberrations 

References

  1. 1.
    Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB (2007) Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 16:1753–1773PubMedCrossRefGoogle Scholar
  2. 2.
    Conklin KA (2004) Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 3:294–300PubMedCrossRefGoogle Scholar
  3. 3.
    Packer L, Rimbach G, Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27:704–724PubMedCrossRefGoogle Scholar
  4. 4.
    Moini H, Guo Q, Packer L (2000) Enzyme inhibition and protein-binding action of the procyanidin-rich french maritime pine bark extract, pycnogenol: effect on xanthine oxidase. J Agric Food Chem 48:5630–5639PubMedCrossRefGoogle Scholar
  5. 5.
    Saliou C, Rimbach G, Moini H, McLaughlin L, Hosseini S, Lee J, Watson R, Packer L (2001) Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radical Biol Med 30:154–160CrossRefGoogle Scholar
  6. 6.
    Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334(2):115–124PubMedCrossRefGoogle Scholar
  7. 7.
    Gulec M, Iraz M, Yilmaz HR, Ozyurt H, Temel I (2006) The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity. Toxicol Ind Health 22:125–130PubMedCrossRefGoogle Scholar
  8. 8.
    Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O (2003) Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 47:49–56CrossRefGoogle Scholar
  9. 9.
    Evangelista CM, Antunes LM, Francescato HD, Bianchi M (2004) Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats. Food Chem Toxicol 42:1291–1297PubMedCrossRefGoogle Scholar
  10. 10.
    Sendao MC, Behling EB, dos Santos RA et al (2006) Comparative effects of acute and subacute lycopene administration on chromosomal aberrations induced by cisplatin in male rats. Food Chem Toxicol 44:1334–1339PubMedCrossRefGoogle Scholar
  11. 11.
    Krizková L, Chovanová Z, Duracková Z, Krajcovic J (2008) Antigenotoxic in vitro activity of plant polyphenols: Pycnogenol® and Ginkgo biloba extract (EGb 761). Phytother Res 22:384–388PubMedCrossRefGoogle Scholar
  12. 12.
    Kim YG, Park HY (2004) The effects of Pycnogenol on DNA damage in vitro and expression of superoxide dismutase and HP1 in Escherichia coli SOD and catalase deficient mutant cells. Phytother Res 18:900–905PubMedCrossRefGoogle Scholar
  13. 13.
    Ulubaş B, Cimen MY, Apa DD, Saritaş E, Muşlu N, Cimen OB (2003) The protective effects of acetylsalicylic acid on free radical production in cisplatin induced nephrotoxicity: an experimental rat model. Drug Chem Toxicol 26(4):259–270PubMedCrossRefGoogle Scholar
  14. 14.
    Ajith TA, Usha S, Nivitha V (2007) Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375(1–2):82–86, Epub 2006 Jun 14PubMedCrossRefGoogle Scholar
  15. 15.
    Cetin R, Devrim E, Kiliçoğlu B, Avci A, Candir O, Durak I (2006) Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J Appl Toxicol 26(1):42–46PubMedCrossRefGoogle Scholar
  16. 16.
    Feng WH, Wei HL, Liu GT (2002) Effect of PYCNOGENOL on the toxicity of heart, bone marrow and immune organs as induced by antitumor drugs. Phytomedicine 9(5):414–418PubMedCrossRefGoogle Scholar
  17. 17.
    Kobuchi H, Virgili F, Packer L (1999) Assay of inducible form of nitric oxide synthase activity: effect of flavonoids and plant extracts. Methods Enzymol 301:504–513PubMedCrossRefGoogle Scholar
  18. 18.
    Aebi H (1984) Catalase in vitro. Meth Enzymol 105:121–126PubMedCrossRefGoogle Scholar
  19. 19.
    Winterbourn CC, Hawkins RE, Brian M, Carrell RW (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341PubMedGoogle Scholar
  20. 20.
    Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erytrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMedGoogle Scholar
  21. 21.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  22. 22.
    Drabkin DL, Austin JH (1935) Spectrophotometric studies. II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 112:51–65Google Scholar
  23. 23.
    Parks DA, Williams TK, Beckman JS (1988) Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am Physiol Soc 254:G768–G774Google Scholar
  24. 24.
    Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N, Savli H (2002) Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16:163–170PubMedCrossRefGoogle Scholar
  25. 25.
    Moron MS, Depierre JW, Mannervik B (1979) Levels of GSH, GR and GST activities in rat lung and liver. Biochim Biophys Acta 582:67PubMedGoogle Scholar
  26. 26.
    Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation, estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209PubMedCrossRefGoogle Scholar
  27. 27.
    Esterbauer H, Chessman KH (1990) Determination of aldeydic lipid peroxidation products: malonaldeyde and 4-hydroxynonenal. Methods Enzymol 186:407–421PubMedCrossRefGoogle Scholar
  28. 28.
    Preston RJ, Au W, Bender MA, Brewen JG, Carrano AV, Heddle JA, McFee AF, Wolff S, Wassom JS (1981) Mammalian in vivo and in vitro cytogenetic assays: a report of the U.S. EPA’s gene-tox programme. Mutat Res 87:143–188PubMedGoogle Scholar
  29. 29.
    Savage JR (1976) Classification and relationships of induced chromosomal structural changes. J Med Genet 3:103–122CrossRefGoogle Scholar
  30. 30.
    Swierenga SH, Heddle JA, Sigal EA, Gilman JP, Brillinger RL, Douglas GR, Nestmann ER (1991) Recommended protocols based on a survey of current practice in genotoxicity testing laboratories, IV. Chromosome aberration and sister chromatid exchange in Chinese hamster ovary, V79 Chinese hamster lung and lymphocyte cultures. Mutat Res 246:301–322PubMedGoogle Scholar
  31. 31.
    Maines MD (1986) Differential effect of cis-platinum (cis-diamminedichloroplatinum) on regulation of liver and kidney haem and haemoprotein metabolism. Possible involvement of gamma-glutamyl-cycle enzymes. Biochem J 237:713–721PubMedGoogle Scholar
  32. 32.
    Dene BA, Maritim AC, Sanders RA, Watkins JB (2005) Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities. J Ocul Pharmacol Ther 21(1):28–35PubMedCrossRefGoogle Scholar
  33. 33.
    Kim YJ, Kang KS, Yokozawa T (2008) The anti-melanogenic effect of pycnogenol by its anti-oxidative actions. Food Chem Toxicol 46(7):2466–2471PubMedCrossRefGoogle Scholar
  34. 34.
    Kim J, Chehade J, Pinnas JL, Mooradian AD (2000) Effect of select antioxidants on malondialdehyde modification of proteins. Nutrition 16(11–12):1079–1081PubMedCrossRefGoogle Scholar
  35. 35.
    Sivonová M, Waczulíková I, Kilanczyk E, Hrnciarová M, Bryszewska M, Klajnert B, Duracková Z (2004) The effect of pycnogenol on the erythrocyte membrane fluidity. Gen Physiol Biophys 23:39–51PubMedGoogle Scholar
  36. 36.
    Pan H, Mukhopadhyay P, Rajesh M, Patel V, Mukhopadhyay B, Gao B, Haskó G, Pacher P (2009) Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther 328(3):708–714PubMedCrossRefGoogle Scholar
  37. 37.
    Chirino YI, Trujillo J, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, Bobadilla NA, Pedraza-Chaverri J (2008) Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 4(176(1)):48–57CrossRefGoogle Scholar
  38. 38.
    MacMillan-Crow LA, Crow JP, Kerby JD (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci 93:11853–11858PubMedCrossRefGoogle Scholar
  39. 39.
    Ramesh G, Reeves WB (2002) TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:835–842PubMedGoogle Scholar
  40. 40.
    Cho KJ, Yun CH, Yoon DY et al (2000) Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7. Toxicol Appl Pharmacol 168:64–71PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Birsen Aydin
    • 1
    Email author
  • Meftun Unsal
    • 2
  • Zulal A. Sekeroglu
    • 3
  • Yavuz Gülbahar
    • 4
  1. 1.Faculty of Science, Department of BiologyAmasya UniversityAmasyaTurkey
  2. 2.Faculty of Medicine, Department of ChestOndokuz Mayis UniversitySamsunTurkey
  3. 3.Faculty of Arts and Sciences, Department of BiologyOrdu UniversityOrduTurkey
  4. 4.Faculty of Veterinary, Department of PathologyOndokuz Mayis UniversitySamsunTurkey

Personalised recommendations